Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

**Abstract
** The increasing incidence of cancer worldwide necessitates the development of innovative treatment strategies. In this context, the focus of this thesis is on the development and evaluation of novel drug delivery systems for targeted cancer therapy. The primary objective is to enhance the efficacy of cancer treatment while minimizing the adverse effects associated with traditional chemotherapy. The thesis begins with an introduction that provides a comprehensive overview of the research topic. It delves into the background of the study, highlighting the current challenges in cancer therapy and the need for targeted drug delivery systems. The problem statement elucidates the limitations of existing treatment modalities and underscores the significance of developing novel approaches to improve patient outcomes. The objectives of the study are clearly defined to address the gaps in current cancer treatment methods. Through a systematic literature review, ten key aspects of drug delivery systems for cancer therapy are critically analyzed to provide a solid foundation for the research. The review encompasses various drug delivery approaches, including nanoparticles, liposomes, and antibody-drug conjugates, focusing on their mechanisms of action and potential applications in targeted cancer therapy. The research methodology section outlines the experimental design and procedures employed in the development and evaluation of novel drug delivery systems. It covers aspects such as formulation design, drug loading techniques, in vitro and in vivo evaluation methods, and data analysis protocols. The methodology is designed to ensure the reproducibility and reliability of the study results. Chapter four presents a detailed discussion of the findings obtained from the evaluation of the novel drug delivery systems. The results are analyzed in relation to the research objectives, highlighting the efficacy and specificity of the developed systems in targeting cancer cells. The discussion also addresses any limitations or challenges encountered during the research process, providing insights for future studies in the field. In the concluding chapter, the key findings of the study are summarized, emphasizing the significance of the developed drug delivery systems for targeted cancer therapy. The conclusions drawn from the research outcomes are presented in light of the initial objectives, highlighting the potential impact of the study on improving cancer treatment outcomes. Recommendations for further research and potential clinical applications of the developed drug delivery systems are also discussed. In conclusion, this thesis contributes to the field of cancer therapy by exploring the development and evaluation of novel drug delivery systems for targeted treatment. The research outcomes provide valuable insights into the potential of these systems to enhance the efficacy and safety of cancer therapy, paving the way for future advancements in precision medicine for cancer patients.